These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24103524)

  • 21. Lack of proliferative activity of surface epithelial inclusion cysts of the ovary.
    Heller DS; Hameed M; Baergen R
    Int J Gynecol Cancer; 2003; 13(3):303-7. PubMed ID: 12801260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
    Körner M; Burckhardt E; Mazzucchelli L
    J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance.
    Zhu J; Zhang G; Lu H
    Front Biosci (Elite Ed); 2012 Jun; 4(8):2645-51. PubMed ID: 22652675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
    Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
    Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.
    Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G
    Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer.
    Amsterdam A; Raanan C; Schreiber L; Polin N; Givol D
    Biochem Biophys Res Commun; 2013 Apr; 433(2):157-62. PubMed ID: 23438436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
    Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
    Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell].
    Lu YH; Zhu H; Wang ZW; Fan XJ; Zhu SJ; Li XH; Wang Y; Lu JJ; Zhu MY
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3107-10. PubMed ID: 22340650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
    Woo MM; Gilks CB; Verhage HG; Longacre TA; Leung PC; Auersperg N
    Gynecol Oncol; 2004 May; 93(2):315-9. PubMed ID: 15099939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian cancer stem cells more questions than answers.
    Ottevanger PB
    Semin Cancer Biol; 2017 Jun; 44():67-71. PubMed ID: 28450177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas.
    Salnikov AV; Bretz NP; Perne C; Hazin J; Keller S; Fogel M; Herr I; Schlange T; Moldenhauer G; Altevogt P
    Br J Cancer; 2013 Apr; 108(7):1449-59. PubMed ID: 23511563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is sphere assay useful for the identification of cancer initiating cells of the ovary?
    Martínez-Serrano MJ; Caballero-Baños M; Vilella R; Vidal L; Pahisa J; Martínez-Roman S
    Int J Gynecol Cancer; 2015 Jan; 25(1):12-7. PubMed ID: 25365589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
    He QZ; Luo XZ; Wang K; Zhou Q; Ao H; Yang Y; Li SX; Li Y; Zhu HT; Duan T
    Cell Physiol Biochem; 2014; 33(1):173-84. PubMed ID: 24504111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.
    Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
    Cell Stem Cell; 2011 Jul; 9(1):50-63. PubMed ID: 21726833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer.
    Ooki A; VandenBussche CJ; Kates M; Hahn NM; Matoso A; McConkey DJ; Bivalacqua TJ; Hoque MO
    Br J Cancer; 2018 Oct; 119(8):961-970. PubMed ID: 30327565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
    Giurgea LN; Ungureanu C; Mihailovici MS
    Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B.
    Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A
    Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.